Plasma pentraxin 3 concentrations in patients with acute pancreatitis

Clinical Laboratory

Volumn 59, Issue 9-10, 2013, Pages 1003-1008

  Kusnierz Cabala, Beata ^a   Gurda Duda, Anna ^a   Dumnicka, Paulina ^a   Panek, Jozefa ^a   Pawlica Gosiewska, Dorota ^a   Kulig, Jan ^a   Solnica, Bogdan ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Acute pancreatitis; Cytokines; Inflammatory markers; Pentraxin 3

Indexed keywords

C REACTIVE PROTEIN; ELASTASE; INTERLEUKIN 18; INTERLEUKIN 6; PENTRAXIN 3; PROCALCITONIN; SCATTER FACTOR; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ACUTE PANCREATITIS; ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GALLSTONE; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; LEUKOCYTE DIFFERENTIAL COUNT; MALE; NEUTROPHIL COUNT; PANCREAS ABSCESS; PROGNOSIS;

ACUTE DISEASE; ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PANCREATITIS; SERUM AMYLOID P-COMPONENT;

EID: 84886399935     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.120821     Document Type: Article

References (36)

1. Bumbasirevic V, Rodenkovic D, Jankovic Z, et al. Severe acute pancreatitis. Overall and early versus late mortality in intensive care units. Pancreas 2009;38:122-5.
2. Muller B, Peri G, Doni A, et al. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med 2001;29:1404-7. (Pubitemid 32641804)
3. Mantovani A, Garlanda C, Doni A, Bottazzi B. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol 2008;28:1-13.
4. Akerfeldt T, Larsson A. Pentraxin 3 increase is much less pronounced than C-reactive protein increase after surgical procedures. Inflammation 2011;34:367-70.
5. Napoleone E, Di Santo A, Peri G, et al. The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation. J Leuk Biol 2004;76:-203-9.
6. de Kruif MD, Limper M, Sierhuis K, et al. PTX3 predicts severe disease in febrile patients at the emergency department. J Infection 2010;60:122-7.
7. Hill AL, Lowes DA, Webster NR, Sheth CC, Gow NAR, Galley HF. Regulation of pentraxin-3 by antioxidants. Br J Anaesth 2009;103:833-9.
8. Moalli F, Jaillon S, Infarzato A, et al. Pathogen recognition by the long pentraxin PTX3. J Biomedicine Biotech 2011;DOI:10.1155/2011/830421.
9. van Rossum AP, Fazzini F, Limburg PC, et al. The prototypic tissue pentraxin PTX 3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages. Arthritis Rheumatism 2004;50:2667-74. (Pubitemid 39062730)
10. Huttunen R, Hurme M, Aittoniemi J, et al. High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteriemic patients: a prospective cohort study. PLOS One 2011;6:e17653.
11. Imamura M, Kawasaki T, Savchenko AS, et al. Lipopolisaccharide induced expression of pentraxin 3 in human neutrophils and monocyte-derived macrophages. Cell Immunol 2007;248:86-94. (Pubitemid 350299022)
12. Deban L, Russo C, Sironi M, et al. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nature Immunol 2010;11:-328-34.
13. Manfredi AA, Rovere-Querini P, Bottazzi B, Garlanda C, Mantovani A. Pentraxins. Humoral innate immunity and tissue injury. Curr Opinion Imunnol 2008;20:538-44.
14. Savchenko AS, Inoue A, Ohashi R, et al. Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis. Pathology International 2011;61:290-7.
15. Deban L, Jaillon S, Garlanda C, Bottazzi B, Mantovani A. Pentraxins innate immunity: lessons from PTX3. Cell Tissue Res 2011;343:237-49.
16. Zhang H, Damas P, Preiser JC. The long way of biomarkers: from bench to bedside. Intensive Care Med 2010;36:565-6.
17. Mauri T, Coppadoro A, Bellani G, et al. Pentraxin 3 in acute respiratory distress syndrome: An early marker of severity. Crit Care Med 2008;16:2302-8.
18. Bollen TL, van Santvoort HC, Besselink MG, et al. The Atlanta Classification of acute pancreatitis revisited. Br J Surg 2008;95:6-21. (Pubitemid 351184911)
19. N Latex SAA test Siemens Healthcare Germany. www.siemens.com/diagnostics
20. N Latex High Sensitivity C-Reactive Protein (hsCRP) test. Siemens Healthcare Germany. www.siemens.com/diagnostics
21. Quantikine Human HGF Immunoassay R&D Systems, Inc. Minneapolis, MN, USA. www.RnDSystems.com
22. rd revised and expanded edition. Thieme Verlag, 2000:162-83.
23. Human PMN Elastase ELISA BioVendor Brno Czech Republic, www.biovendor.com
24. Quantikine Human IL-6 Immunoassay R&D Systems, Inc. Minneapolis, MN, USA. www.RnDSystems.com
25. Human IL-18 ELISA Kit MBL Medical & Biological Laboratories Co. Nagoya, Japan. www.mbl.co.jp
26. Quantikine Human sTNFRII Immunoassay R&D Systems, Inc. Minneapolis, MN, USA. www.RnDSystems.com
27. Quantikine Human Pentraxin 3/TSG-14 Immunoassay R&D Systems, Inc. Minneapolis, MN, USA. www.RnDSystems.com
28. Khan A, Perekh D, Cho Y, et al. Improved prediction of outcome in patients with severe acute pancreatitis by the APACHE II score at 48 hours after hospital admission compared with the APACHE II score at admission. Arch Surg 2002;137:1136-40. (Pubitemid 35155247)
29. Takeda K, Yokoe M, Takada T, et al. Assessment of severity of acute pancreatitis according to new prognostic factors and CT grading. J Hepatobiliary Pancreat Sci 2010;17:37-44.
30. Mofidi R, Patil PV, Suttie SA, Parks RW. Risk assessment in acute pancreatitis. Br J Surg 2009;96:137-50.
31. Rau BM. Predicting severity of acute pancreatitis. Curr Gastroenterology Reports 2007;9:107-15. (Pubitemid 46647522)
32. Pavlidis TE, Pavlidis ET, Sakantamis AK. Advances in prognostic factors in acute pancreatitis: a mini-review. Hepatobiliary Pancreat Dis Int 2010;9:482-6.
33. Pezzilli R, Melzi D'Eril G, Morselli-Labate A, Merlini G, Barakat B, Bosoni T. Serum amyloid A, procalcitonin, and C-reactive protein in early assessment of severity of acute pancreatitis. Dig Dis Sci 2000;45:1072-8. (Pubitemid 30409447)
34. Sprong T, Peri G, Neeleman C, et al. Pentraxin 3 and C-reactive protein in severe meningococcal disease. Shock 2009;31:28-32.
35. Jaillon S, Peri G, Delneste Y, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 2007;204:793-804. (Pubitemid 46631609)
36. Miyamoto T, Qureshi AR, Heimburger O, et al. Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease. Clin Jam Soc Nephrol 2011;6:2785-91.